Surgical Treatment for Capsular Contracture: A New Paradigm and Algorithm.

Area of Science:

• Plastic Surgery
• Regenerative Medicine
• Biomaterials

Background:

• Capsular contracture recurrence is common with conventional breast augmentation surgery.
• Acellular dermal matrix (ADM) enhances outcomes but increases surgical time and cost.
• A novel treatment algorithm selectively utilizes ADM to balance efficacy and resource utilization.

Purpose of the Study:

• To evaluate a new treatment algorithm for capsular contracture using selective acellular dermal matrix (ADM) application.
• To optimize success rates for breast augmentation patients while minimizing ADM-related drawbacks.
• To compare outcomes of the selective ADM algorithm against conventional and non-selective ADM treatments.

Main Methods:

• Retrospective cohort study of 180 patients undergoing 217 surgical treatments for Baker grade III/IV capsular contracture (2007-2018).
• Data collected on patient demographics, augmentation details, contracture severity, and surgical interventions.
• Treatment success defined as achieving Baker grade II or better post-operatively.

Main Results:

• Conventional treatment success: 72.5% (1st), 62.5% (2nd), 50.0% (3rd occurrence).
• ADM success: 96.9% overall.
• Selective ADM algorithm improved overall success to 85.6% (vs. 64.2% without), with bilateral contracture and prior failure increasing odds of recurrence.

Conclusions:

• Selective acellular dermal matrix (ADM) use significantly enhances capsular contracture treatment success rates.
• The proposed algorithm achieves over 85% overall success and nearly 100% in select cases.
• This strategy effectively manages recurrent and severe capsular contracture following breast augmentation.